<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="93986">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01767155</url>
  </required_header>
  <id_info>
    <org_study_id>AEZS -108-050</org_study_id>
    <nct_id>NCT01767155</nct_id>
  </id_info>
  <brief_title>Study Comparing AEZS-108/ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) to Doxorubicin as a Second Line Therapy of Endometrial Cancer</brief_title>
  <official_title>Randomized Controlled Study Comparing AEZS-108 With Doxorubicin as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AEterna Zentaris</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AEterna Zentaris</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <authority>Belgium: Federal Agency for Medicines and Health Products, FAMHP</authority>
    <authority>Czech Republic: State Institute for Drug Control</authority>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>Ireland: Irish Medicines Board</authority>
    <authority>Italy: The Italian Medicines Agency</authority>
    <authority>Netherlands: Medicines Evaluation Board (MEB)</authority>
    <authority>Norway: Norwegian Medicines Agency</authority>
    <authority>Sweden: Medical Products Agency</authority>
    <authority>Israel: Ministry of Health</authority>
    <authority>Austria: Institute for Marketing Authorisation of Medicinal Products and Lifecycle Management</authority>
    <authority>Bulgaria: Bulgarian Drug Agency</authority>
    <authority>Canada: Health Canada</authority>
    <authority>Romania: National Medicines Agency</authority>
    <authority>Bosnia and Herzegovina: Agency for Drugs and Medical Devices</authority>
    <authority>Ukraine:State Expert Centre of Ministry of Health of Ukraine</authority>
    <authority>Russia: Ministry of Health of the Russian Federation</authority>
    <authority>Poland: Office for Registration of Medicinal Products, Medical Devices and Biologocal Products</authority>
    <authority>Belarus:Ministry of HealthCare of the Republic of the Belarus</authority>
    <authority>Spain:Spanish Agency for Medicines and Health Products</authority>
    <authority>Norway:Norvegian Medicines Agency</authority>
    <authority>Netherlands: Medicines Evaluation Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open-label, randomized, active-controlled, two-arm Phase III study to compare the efficacy
      and safety of AEZS-108 and doxorubicin. The study will include about 500 patients with
      endometrial cancer resistant to platinum/taxane-based chemotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Compare the overall survival (OS) of patients treated with AEZS-108 to the OS of patients treated with doxorubicin.</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare efficacy based on objective response rate (ORR).</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare efficacy based on progression-free survival (PFS).</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare efficacy based on clinical benefit rate (CBR).</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Endometrial Cancer</condition>
  <arm_group>
    <arm_group_label>AEZS-108 / zoptarelin doxorubicin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>267 mg/m2 by 2-hour intravenous infusion, on Day 1 of 21-day (3-week) cycles up to 9 cycles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>doxorubicin/ standard chemotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>60 mg/m2 by intravenous bolus injection or 1-hour intravenous infusion, on Day 1 of 21-day (3-week) cycles</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AEZS-108 / zoptarelin doxorubicin</intervention_name>
    <description>267 mg/m2 by 2-hour intravenous infusion, on Day 1 of 21-day (3-week) cycles for a maximum of 9 cycles</description>
    <arm_group_label>AEZS-108 / zoptarelin doxorubicin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>doxorubicin</intervention_name>
    <description>60 mg/m2 by intravenous bolus injection or 1-hour intravenous infusion, on Day 1 of 21-day (3-week) cycles</description>
    <arm_group_label>doxorubicin/ standard chemotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women ≥ 18 years of age

          2. Histologically confirmed endometrial cancer

          3. Advanced (FIGO stage III or IV), recurrent or metastatic disease.

          4. Measurable or non-measurable disease that has progressed since last treatment.

          5. 5. Patients with advanced, recurrent or metastatic endometrial cancer who have
             received one chemotherapeutic regimen with platinum and taxane (either as adjuvant or
             as first line treatment) and who have progressed.

          6. Availability of fresh or archival FFPE tumor specimens for analysis of LHRH receptor
             expression.

        Exclusion Criteria:

          1. ECOG performance status &gt; 2.

          2. Inadequate hematologic, hepatic or renal function

          3. Red blood cell transfusion within 2 weeks prior to anticipated start of study
             treatment.

          4. History of myocardial infarction, acute inflammatory heart disease, unstable angina,
             or uncontrolled arrhythmia within the past 6 months.

          5. Impaired cardiac function defined as left ventricular ejection fraction (LVEF) &lt; 50 %
             (or below the study site's lower limit of normal) as measured by MUGA or ECHO.

          6. Concomitant use of prohibited therapy (specified in protocol)

          7. Chemo-, immune-, or hormone-therapy within 5 elimination half life times or 4 weeks
             prior to randomization, whichever is the shorter. Radiotherapy (including pre- or
             post-operative brachytherapy) within 4 weeks prior to randomization.

          8. Previous anthracycline-based chemotherapy (daunorubicin, doxorubicin, epirubicin,
             idarubicin, mitoxantrone and valrubicin), in any formulation.

          9. Anticipated ongoing concomitant anticancer therapy during the study.

         10. History of serious co-morbidity or uncontrolled illness that would preclude study
             therapy, such as active tuberculosis or any other active infection.

         11. Brain metastasis, leptomeningeal disease.

         12. Pregnant or lactating female or female of child-bearing potential not employing
             adequate contraception.

         13. Subjects with known hypersensitivity to peptide drugs, including LHRH agonists.

         14. Receipt of 2 or more prior cytotoxic chemotherapy regimens for advanced, recurrent,
             or metastatic endometrial cancer.

         15. Prior treatment with AEZS-108.

         16. Use of LHRH agonist or antagonist treatment within 6 months prior to randomization.

         17. Malignancy within last 5 years except non-melanoma skin cancer.

         18. Any concomitant disease or condition which would interfere with the subjects' proper
             completion of the protocol assignment.

         19. Concomitant or recent treatment with other investigational drug (within 4 weeks or 5
             elimination half life times prior to anticipated start of study treatment).

         20. Lack of ability or willingness to give informed consent.

         21. Anticipated non-availability for study visits/procedures.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Scott Miller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center, Dallas, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hani Gabra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London Hammersmith Campus, London, UK</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Herbert Sindermann, PhD</last_name>
    <phone>+49 69 4 26 02 - 3429</phone>
    <email>HSindermann@aezsinc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Joseph's Hospital and Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelli Williamson</last_name>
      <phone>602-406-6689</phone>
    </contact>
    <investigator>
      <last_name>Lyndsay Willmott, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California, Irvine - Medical Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868-3200</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Reiter</last_name>
      <phone>714-456-6846</phone>
    </contact>
    <investigator>
      <last_name>Krishnansu S Tewari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Kissane</last_name>
      <phone>720-848-7202</phone>
    </contact>
    <investigator>
      <last_name>Monique A. Spillman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Alexander</last_name>
      <phone>860-545-3553</phone>
    </contact>
    <investigator>
      <last_name>Amy Brown, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Hospital of Central Connecticut</name>
      <address>
        <city>New Britain</city>
        <state>Connecticut</state>
        <zip>06050</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siobhan Reilly</last_name>
      <phone>860-224-5900</phone>
      <phone_ext>6718</phone_ext>
    </contact>
    <investigator>
      <last_name>James Hoffman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Tiemann</last_name>
      <phone>813-745-7272</phone>
    </contact>
    <investigator>
      <last_name>Robert Wenham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northside Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qun Zeng</last_name>
      <phone>404-845-5053</phone>
    </contact>
    <investigator>
      <last_name>Benedict Benigno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Bers, CCRP</last_name>
      <phone>312-472-5726</phone>
    </contact>
    <investigator>
      <last_name>Nikki Neubauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Stockman</last_name>
      <phone>319-356-2015</phone>
    </contact>
    <investigator>
      <last_name>David Bender, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women's Cancer Center</name>
      <address>
        <city>Covington</city>
        <state>Louisiana</state>
        <zip>70433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Thomas</last_name>
      <phone>985-892-2252</phone>
    </contact>
    <investigator>
      <last_name>Patricia Braly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland Greenebaum Cancer Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Besche</last_name>
      <phone>410-328-8610</phone>
    </contact>
    <investigator>
      <last_name>Sarah Temkin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital Cancer Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Don Dizon</last_name>
      <phone>617-724-4800</phone>
    </contact>
    <investigator>
      <last_name>Don Dizon, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dana-Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siobhan Collins</last_name>
      <phone>617-632-2580</phone>
    </contact>
    <investigator>
      <last_name>Don Dizon, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medecine</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynne Lippmann</last_name>
      <phone>314-362-1760</phone>
    </contact>
    <investigator>
      <last_name>Premal Thaker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan-Kettering Cancer Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Konner, MD</last_name>
      <phone>646-888-4219</phone>
    </contact>
    <investigator>
      <last_name>Jason Konnor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hope Women's Cancer Centers / Mission Hospital, Inc.</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Murphy</last_name>
      <phone>828-670-8403</phone>
    </contact>
    <investigator>
      <last_name>Timothy Vanderkwaak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Levine Cancer Institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Norek</last_name>
      <phone>980-442-2300</phone>
    </contact>
    <investigator>
      <last_name>David L. Tait, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Roger Maris Cancer Center</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Collette Springman</last_name>
      <phone>605-328-1384</phone>
    </contact>
    <investigator>
      <last_name>Maria Bell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leena Hiremath</last_name>
      <phone>614-366-9088</phone>
    </contact>
    <investigator>
      <last_name>David O'Malley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peggy and Charles Oklahoma Cancer Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Stephens</last_name>
      <phone>405-271-8777</phone>
    </contact>
    <investigator>
      <last_name>Scott McMeekin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Research/USD</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Collette Springman</last_name>
      <phone>605-328-1384</phone>
    </contact>
    <investigator>
      <last_name>Maria Bell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-9179</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Villalobos</last_name>
      <phone>214-648-7010</phone>
    </contact>
    <investigator>
      <last_name>David Scott Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomothy Howland</last_name>
      <phone>434-243-0032</phone>
    </contact>
    <investigator>
      <last_name>Linda Duska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospitals</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Jeffords</last_name>
      <phone>571-308-1830</phone>
      <phone_ext>344</phone_ext>
    </contact>
    <investigator>
      <last_name>Larry Maxwell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henrico Doctor's Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deidre Belcher</last_name>
      <phone>804-289-4672</phone>
    </contact>
    <investigator>
      <last_name>Cecelia Boardman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Universität Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain-Gustave Zeimet</last_name>
      <phone>+43 (0)50504-24155</phone>
    </contact>
    <investigator>
      <last_name>Alain-Gustave Zeimet, Prof.Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Universität Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain-Gustave Zeimet</last_name>
      <phone>+43 (0)50504-24155</phone>
    </contact>
    <investigator>
      <last_name>Alain-Gustave Zeimet, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minsk City Clinical Oncologic Dispensary</name>
      <address>
        <city>Minsk</city>
        <country>Belarus</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yauheni Baranau</last_name>
      <phone>+375 29 627 2018</phone>
    </contact>
    <investigator>
      <last_name>Yauheni Baranau, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alexandrov National Cancer centre of Belarus</name>
      <address>
        <city>Minsk</city>
        <zip>223040</zip>
        <country>Belarus</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Zhuravkin</last_name>
      <phone>+375 17 265 3781</phone>
    </contact>
    <investigator>
      <last_name>Edvard Zhavrid, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mogilev Regional Clinical Oncologic Dispensary</name>
      <address>
        <city>Mogilev</city>
        <zip>212018</zip>
        <country>Belarus</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Ezubchyk</last_name>
      <phone>+375 29 664 6877</phone>
    </contact>
    <investigator>
      <last_name>Elena Ezubchyk, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vitebsk Regional Clinical Oncologic Dispensary</name>
      <address>
        <city>Vitebsk</city>
        <zip>210603</zip>
        <country>Belarus</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia Matora</last_name>
      <phone>+375 21 257 2179</phone>
    </contact>
    <investigator>
      <last_name>Valiantina Kliuchanok, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Jules Bordet</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Kerger</last_name>
      <phone>+32 2 541 73 96</phone>
    </contact>
    <investigator>
      <last_name>Joseph Kerger, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZ Leuven - Campus Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tine Op de beeck</last_name>
      <phone>+32 16 34 29 23</phone>
    </contact>
    <investigator>
      <last_name>Ignace Vergote, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Centre Liege University_CHU Sart Tilman</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic Kridelka</last_name>
      <phone>+32 43 67 82 50</phone>
    </contact>
    <investigator>
      <last_name>Frederic Kridelka, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHWAPI</name>
      <address>
        <city>Tournai</city>
        <zip>7500</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivia Ponchau</last_name>
      <phone>+32 69 88 50 30</phone>
    </contact>
    <investigator>
      <last_name>Catherine Dopchie, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Center Banja Luka, Oncology Clinic</name>
      <address>
        <city>Banja Luka</city>
        <zip>78000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zivko Vranjes, Dr</last_name>
      <phone>+387 65 880 811</phone>
    </contact>
    <investigator>
      <last_name>Zivko Vranjes, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Clinical Hospital Mostar, Oncology clinic</name>
      <address>
        <city>Mostar</city>
        <zip>88000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>. Inga Marijanovic, Dr</last_name>
      <phone>+387 61 194 686</phone>
    </contact>
    <investigator>
      <last_name>Inga Marijanovic, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Centre University of Sarajevo</name>
      <address>
        <city>Sarajevo</city>
        <zip>71000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anes Pasic</last_name>
      <phone>00 387 217 499 / 00 387 33 298</phone>
    </contact>
    <investigator>
      <last_name>Anes Pasic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Specialized Hospital for Active Treatment in Obstetrics and Gynecology</name>
      <address>
        <city>Pleven</city>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grigor Gortchev</last_name>
      <phone>+359 887 511 531</phone>
    </contact>
    <investigator>
      <last_name>Grigor Gortchev, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cross Cancer Institute</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 1Z2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanda Gaudon</last_name>
      <phone>(780) 577-8029</phone>
    </contact>
    <investigator>
      <last_name>Katia Tonkin, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Cancer Center</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judy Quintos</last_name>
      <phone>416-946-4501</phone>
      <phone_ext>5322</phone_ext>
    </contact>
    <investigator>
      <last_name>Amit M Oza, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Notre Dame - CHUM</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bonny Choy</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>24672</phone_ext>
    </contact>
    <investigator>
      <last_name>Diane Provencher, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McGill University</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1S6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Penny Chipman</last_name>
      <phone>514-398-1444</phone>
    </contact>
    <investigator>
      <last_name>Suzy Lau, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natacha Albarracin</last_name>
      <phone>(514) 934-1934</phone>
      <phone_ext>31975</phone_ext>
    </contact>
    <investigator>
      <last_name>Lucy Gilbert, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hotel Dieu de Quebec- CHUQ</name>
      <address>
        <city>Quebec</city>
        <zip>G1R 2J6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Theresa Jones</last_name>
      <phone>418 691-5181</phone>
    </contact>
    <investigator>
      <last_name>Vincent Castonguay, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Masarykův onkologický ústav</name>
      <address>
        <city>Brno</city>
        <zip>65653</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Haičmanová</last_name>
      <phone>00420-543135222</phone>
    </contact>
    <investigator>
      <last_name>Josef Chovanec, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fakultní nemocnice Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>77520</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magda Šimková</last_name>
      <phone>420588442522</phone>
    </contact>
    <investigator>
      <last_name>Bohuslav Melichar, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Všeobecná fakultní nemocnice v Praze</name>
      <address>
        <city>Praha</city>
        <zip>12851</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Cibula</last_name>
      <phone>00420 224 967 481</phone>
    </contact>
    <investigator>
      <last_name>David Cibula, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St James's Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>8</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dearbhaile O'Donnell</last_name>
      <phone>00 353 1 410 3973</phone>
    </contact>
    <investigator>
      <last_name>Dearbhaile O'Donnell, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mater Private Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>7</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Smith</last_name>
      <phone>00 353 1 8034838</phone>
    </contact>
    <investigator>
      <last_name>David Gallagher, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mater Misericordiae University Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>7</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Smith</last_name>
      <phone>00 353 1 8034838</phone>
    </contact>
    <investigator>
      <last_name>David Gallagher, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Galway</name>
      <address>
        <city>Galway</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maccon Keane</last_name>
      <phone>00 353 91 544735</phone>
    </contact>
    <investigator>
      <last_name>Maccon Keane, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Waterford Regional Hospital</name>
      <address>
        <city>Waterford</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elaine S Shanahan</last_name>
      <phone>00 353 51 848934</phone>
    </contact>
    <investigator>
      <last_name>Paula Calvert, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barzilai Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <zip>78278</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frida Barak, Dr</last_name>
      <phone>08-6745378</phone>
    </contact>
    <investigator>
      <last_name>Frida Barak, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amnon Amit, Dr</last_name>
      <phone>04-8543872</phone>
    </contact>
    <investigator>
      <last_name>Amnon Amit, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah Hospital</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Edelmann, Dr</last_name>
      <phone>02-6777365</phone>
    </contact>
    <investigator>
      <last_name>David Eldelmann, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Davidoff Center, Rabin Medical Center</name>
      <address>
        <city>Petah-Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claude Koren, Dr</last_name>
      <phone>03-9378002</phone>
    </contact>
    <investigator>
      <last_name>Claude Koren, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oncology Institute Kaplan</name>
      <address>
        <city>Rehovot</city>
        <zip>76100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adelya Yachnin, Dr</last_name>
      <phone>08-9441975</phone>
    </contact>
    <investigator>
      <last_name>Adelya Yachnin, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Matceyevsky, Dr</last_name>
      <phone>03-6973997</phone>
    </contact>
    <investigator>
      <last_name>Diana Matceyevsky, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52661</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamar Perri, Dr</last_name>
      <phone>972-52-6666444</phone>
    </contact>
    <investigator>
      <last_name>Tamar Perri, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari</name>
      <address>
        <city>Bari</city>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luigi Selvaggi</last_name>
      <phone>+39 080 5478986</phone>
    </contact>
    <investigator>
      <last_name>Luigi Selvaggi, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria di Modena</name>
      <address>
        <city>Modena</city>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Sabbatini</last_name>
      <phone>+39 059 4222648</phone>
    </contact>
    <investigator>
      <last_name>Roberto Sabbatini, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Nazionale Tumori IRCCS</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmela Pisano</last_name>
      <phone>+39 081 5903637</phone>
    </contact>
    <investigator>
      <last_name>Carmela Pisano, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Oncologico Veneto, IRCCS</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pier Franco Conte</last_name>
      <phone>+39 049 8215931</phone>
    </contact>
    <investigator>
      <last_name>Pier Franco Conte, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Ospedali Riuniti Marche Nord</name>
      <address>
        <city>Pesaro</city>
        <zip>61122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giammaria Fiorentini</last_name>
      <phone>+39 0721 364124</phone>
    </contact>
    <investigator>
      <last_name>Giammaria Fiorentini, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico A. Gemelli</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Scambia</last_name>
      <phone>+39 06 30156279</phone>
    </contact>
    <investigator>
      <last_name>Giovanni Scambia, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyda ter Hofstede</last_name>
      <email>trialmedonc@amc.uva.nl</email>
    </contact>
    <contact_backup>
      <last_name>Eva van Daalen</last_name>
      <email>trialmedonc@amc.uva.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Anne Marie Westermann, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center (UMC)</name>
      <address>
        <city>HX Maastricht</city>
        <zip>6229</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy Lalisang</last_name>
      <phone>+31 43 3876007</phone>
    </contact>
    <investigator>
      <last_name>Roy Lalisang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Norwegian Radium Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0310</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunnar Kristensen</last_name>
      <phone>+47 22934000</phone>
    </contact>
    <investigator>
      <last_name>Gunnar Kristensen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helse Stavanger HF, Stavanger Universitetssjukhus</name>
      <address>
        <city>Stavanger</city>
        <zip>NO-4068</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bent Fiane</last_name>
      <phone>004751519470</phone>
    </contact>
    <investigator>
      <last_name>Bent Fiane, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bialostockie Centrum Onkologii</name>
      <address>
        <city>Bialystok</city>
        <zip>15-027</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beata Mackowiak-Matejczyk</last_name>
      <phone>+48 85 664 67 32.</phone>
    </contact>
    <investigator>
      <last_name>Beata Mackowiak-Matejczyk, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>I Klinika Ginekologii Onkologicznej i Ginekologii</name>
      <address>
        <city>Lublin</city>
        <zip>20-081</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Kotarski, Prof.</last_name>
      <phone>+48815327847</phone>
    </contact>
    <investigator>
      <last_name>Jan Kotarski, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Szpital Specjalistyczny</name>
      <address>
        <city>Olsztyn</city>
        <zip>10-561</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malgorzata Sikorska</last_name>
      <phone>+48895386563</phone>
    </contact>
    <investigator>
      <last_name>Malgorzata Sikorska, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NZOZ Magodent, Szpital Onkologiczny</name>
      <address>
        <city>Warszawa</city>
        <zip>03-291</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malgorzata Stelmaszuk</last_name>
      <phone>+48 22 326 98 66</phone>
    </contact>
    <investigator>
      <last_name>Malgorzata Stelmaszuk</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Terapii Współczesnej ul.</name>
      <address>
        <city>Łódź</city>
        <zip>90-242</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malgorzata Ułańska</last_name>
      <phone>+48 42 230 06 09</phone>
    </contact>
    <investigator>
      <last_name>Malgorzata Ułańska, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oncolab</name>
      <address>
        <city>Craiova</city>
        <state>Dolj county</state>
        <zip>200385</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis Diaconescu</last_name>
      <phone>0040 251 531 088</phone>
    </contact>
    <investigator>
      <last_name>Michael Schenker, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean Mures</name>
      <address>
        <city>Targu Mures</city>
        <state>Mures county</state>
        <zip>540072</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toganel Cornelia</last_name>
      <phone>0040 265 210 947</phone>
    </contact>
    <investigator>
      <last_name>Toganel Cornelia, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oncology Institute &quot;Prof. Dr. I. Chiricuta&quot;</name>
      <address>
        <city>Cluj Npaoca</city>
        <zip>400015</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Calin Cainap</last_name>
      <phone>+40 264 598 361</phone>
    </contact>
    <investigator>
      <last_name>Calin Ioan Cainap, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta &quot;Sf. Ioan cel Nou&quot;</name>
      <address>
        <city>Suceava</city>
        <zip>720237</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toderas Mihai</last_name>
      <phone>0040230222098</phone>
    </contact>
    <investigator>
      <last_name>Doina Elena Ganea, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oncomed</name>
      <address>
        <city>Timisoara</city>
        <zip>300239</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela  Elvira Sirbu, Dr</last_name>
      <phone>0040 256 495 403</phone>
    </contact>
    <investigator>
      <last_name>Daniela Elvira Sirbu, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FGBU &quot;RONC n.a. N.N. Blokhin&quot;</name>
      <address>
        <city>Moscow</city>
        <zip>115478</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dmitry Komov</last_name>
      <phone>+7 499 324 7248</phone>
    </contact>
    <investigator>
      <last_name>Dmitry Komov, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nizhny Novgorod Regional Oncology Dispensary</name>
      <address>
        <city>Nizhny Novgorod</city>
        <zip>603081</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vitaliy Mihaylovich Terekhov</last_name>
      <phone>007 831 4643777</phone>
    </contact>
    <investigator>
      <last_name>Marina Matrosova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pyatigorsk Regional Oncology Dispensary</name>
      <address>
        <city>Pyatigorsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Vladimirov</last_name>
      <phone>+78793 394902</phone>
    </contact>
    <investigator>
      <last_name>Vladimir Vladimirov, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>FGBU &quot;NIIO n.a. N.N. Petrov&quot;</name>
      <address>
        <city>Saint-Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roman Donkikh</last_name>
      <phone>- + 7 (812) 439-95-15</phone>
    </contact>
    <investigator>
      <last_name>Roman Donkikh, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Budget Institution of Health / Leningrad Regional Oncological Dispensary</name>
      <address>
        <city>St. Petersburg</city>
        <zip>191014</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tatiana Potetyurina</last_name>
      <phone>+7 921 940-15-43</phone>
    </contact>
    <investigator>
      <last_name>Olga Mikheeva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint-Petersburg State Budgetary Institution Healthcare &quot;City Clinical Oncology Center&quot;</name>
      <address>
        <city>St. Petersburg</city>
        <zip>198255</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georgy Manikhas</last_name>
      <phone>+7 812 7566368</phone>
    </contact>
    <investigator>
      <last_name>Alla Lisyanskaya, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Republican Clinical Oncology Dispensary</name>
      <address>
        <city>Ufa</city>
        <zip>450071</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irina Rakhmatullina</last_name>
      <phone>+7 917 7791312</phone>
    </contact>
    <investigator>
      <last_name>Irina Rakhmatullina, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Volgograd Regional Oncology Dispensary #3</name>
      <address>
        <city>Volzhsky</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ksenia Babina</last_name>
      <phone>- +7 8443 310663</phone>
    </contact>
    <investigator>
      <last_name>Ksenia Babina, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Vall d´Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Oaknin</last_name>
      <phone>+34. 93.274.60.85</phone>
    </contact>
    <investigator>
      <last_name>Ana Oaknin, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28045</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesús Jiménez</last_name>
      <phone>0034 913908376</phone>
    </contact>
    <investigator>
      <last_name>Jesús Jiménez, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ramon Y Cajal Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Barba</last_name>
      <phone>0034913368263</phone>
    </contact>
    <investigator>
      <last_name>Eva Guerra, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Casado</last_name>
      <phone>+34 91 330 30 00</phone>
      <phone_ext>7551/7549</phone_ext>
    </contact>
    <investigator>
      <last_name>Antonio Casado, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MD Anderson cáncer center</name>
      <address>
        <city>Madrid</city>
        <zip>28033</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio G Martín</last_name>
      <phone>917878600</phone>
    </contact>
    <investigator>
      <last_name>Antonio G Martín, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Valenciano de Oncologia</name>
      <address>
        <city>Valencia</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Mallol</last_name>
      <phone>96 110 46 06</phone>
    </contact>
    <investigator>
      <last_name>Ignacio Romero, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zina Memorial Cancer Hospital (LISSOD)</name>
      <address>
        <city>Plyuty</city>
        <state>Kiev region</state>
        <zip>08720</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alla Lychko</last_name>
      <phone>00380445209401</phone>
    </contact>
    <investigator>
      <last_name>Alla Vinnytska, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Municipal institution &quot;Dnipropetrovsk City Multidisciplinary Clinical Hospital No. 4&quot;</name>
      <address>
        <city>Dnepropetrovsk</city>
        <zip>49102</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Illiya Balakin</last_name>
      <phone>00380567417418</phone>
    </contact>
    <investigator>
      <last_name>Igor Bondarenko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CCMP I Donetsk Regional Anticancer Center</name>
      <address>
        <city>Donetsk</city>
        <zip>83092</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pavlo Lyfar</last_name>
      <phone>00380622239503</phone>
    </contact>
    <investigator>
      <last_name>Natalia Lisovska, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Public health enterprise &quot;Kharkov regional Clinical Oncological Center&quot;</name>
      <address>
        <city>Kharkov</city>
        <zip>61070</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladislav Bakhtalovskiy</last_name>
      <phone>+380573150124</phone>
    </contact>
    <investigator>
      <last_name>Yuri Vinnyk, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kiev City Clinical Oncology Center</name>
      <address>
        <city>Kiev</city>
        <zip>03115</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olena Manzhura</last_name>
      <phone>00380444508239</phone>
    </contact>
    <investigator>
      <last_name>Olena Manzhura, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zakarpatskyi Regional Clinical Oncology Dispensary</name>
      <address>
        <city>Uzhgorod</city>
        <zip>88014</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Taras Shlakhta</last_name>
      <phone>+380312615613</phone>
    </contact>
    <investigator>
      <last_name>Andriy Rusyn, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vinnitsa Regional Clinical Oncology Dispensary</name>
      <address>
        <city>Vinnitsa</city>
        <zip>21029</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oksana Mashevska</last_name>
      <phone>00380432511434</phone>
    </contact>
    <investigator>
      <last_name>Serhiy Odarchenko, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Royal Marsden Hospital NHS Foundation Trust</name>
      <address>
        <city>Sutton</city>
        <state>Surrey</state>
        <zip>SM2 5PT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susana Banerjee</last_name>
      <phone>00 44 208 661 3539</phone>
    </contact>
    <investigator>
      <last_name>Susana Banerjee, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Clatterbridge Cancer Centre NHS Foundation Trust</name>
      <address>
        <city>Bebington</city>
        <state>Wirral</state>
        <zip>CH63 4JY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Lomax</last_name>
      <phone>+44 151 482 7804</phone>
      <phone_ext>4926</phone_ext>
    </contact>
    <investigator>
      <last_name>John Green, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Coventry and Warwickshire NHS Trust</name>
      <address>
        <city>Coventry</city>
        <zip>CV2 2DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracey Preston</last_name>
      <phone>+44 2476 967476</phone>
      <phone_ext>27476</phone_ext>
    </contact>
    <investigator>
      <last_name>Christopher Poole, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Imperial college Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daisy Shinmar</last_name>
      <phone>00 44 208 383 6457</phone>
    </contact>
    <investigator>
      <last_name>Hani Gabra, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nottingham City Hospital NHS Trust</name>
      <address>
        <city>Nottingham</city>
        <zip>NG5 1PB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Chan</last_name>
      <phone>0044 115 969 1169</phone>
      <phone_ext>57298</phone_ext>
    </contact>
    <investigator>
      <last_name>Stephan Chan, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Austria</country>
    <country>Belarus</country>
    <country>Belgium</country>
    <country>Bosnia and Herzegovina</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Czech Republic</country>
    <country>Ireland</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 22, 2014</lastchanged_date>
  <firstreceived_date>January 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
    <mesh_term>Sarcoma, Endometrial Stromal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Doxorubicin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
